reduce insulin dose when starting glp-1 receptor agonist agonists are transforming diabetes care by improving blood sugar control, supporting weight loss, and reducing cardiovascular risk used appropriately. Evidence-based therapy selection, correct dosing, and patient counseling are How Much GLP-1 Do You
Description
GLP-1RAs such as semaglutide and liraglutide (Saxenda, Novo Nordisk) are employed in weight loss regimens
Author Correction: Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial
Additionally, the importance of optimized delivery strategies to ensure sustained and controlled release of GLP-1 analogs is discussed
Glucagon-like peptide-1 (GLP-1) is an incretin hormone produced primarily by specialized L-cells in the distal small intestine and colon
The GLP-1 receptor (GLP-1R), which mediates the biological effects of the hormone with relevance for and beyond CVD, is present across many organs and tissues in humans (Figure 1)
